These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 37009042)

  • 1.
    Kim B; Lee HS; Kim HJ; Lee H; Lee IY; Ock S; Kwon S; Kang SS; Choi Y
    Food Sci Biotechnol; 2023 Apr; 32(5):697-704. PubMed ID: 37009042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoglycemic efficacy and safety of Momordica charantia (bitter melon) in patients with type 2 diabetes mellitus.
    Kim SK; Jung J; Jung JH; Yoon N; Kang SS; Roh GS; Hahm JR
    Complement Ther Med; 2020 Aug; 52():102524. PubMed ID: 32951763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bitter Melon Extract Yields Multiple Effects on Intestinal Epithelial Cells and Likely Contributes to Anti-diabetic Functions.
    Chang CI; Cheng SY; Nurlatifah AO; Sung WW; Tu JH; Lee LL; Cheng HL
    Int J Med Sci; 2021; 18(8):1848-1856. PubMed ID: 33746602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bitter Melon (Momordica charantia) Extract Inhibits Tumorigenicity and Overcomes Cisplatin-Resistance in Ovarian Cancer Cells Through Targeting AMPK Signaling Cascade.
    Yung MM; Ross FA; Hardie DG; Leung TH; Zhan J; Ngan HY; Chan DW
    Integr Cancer Ther; 2016 Sep; 15(3):376-89. PubMed ID: 26487740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of dietary wild bitter melon (Momordica charantia var. abbreviate Ser.) extract on glucose and lipid metabolism in HFD/STZ-induced type 2 diabetic rats.
    Sun K; Ding M; Fu C; Li P; Li T; Fang L; Xu J; Zhao Y
    J Ethnopharmacol; 2023 Apr; 306():116154. PubMed ID: 36634725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bitter melon (Momordica charantia): a review of efficacy and safety.
    Basch E; Gabardi S; Ulbricht C
    Am J Health Syst Pharm; 2003 Feb; 60(4):356-9. PubMed ID: 12625217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Momordica charantia extract on insulin resistance and the skeletal muscle GLUT4 protein in fructose-fed rats.
    Shih CC; Lin CH; Lin WL; Wu JB
    J Ethnopharmacol; 2009 May; 123(1):82-90. PubMed ID: 19429344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bitter melon fruit extract enhances intracellular ATP production and insulin secretion from rat pancreatic
    Shimada T; Kato F; Dwijayanti DR; Nagata T; Kinoshita A; Okuyama T; Nishizawa M; Mukai E
    Br J Nutr; 2022 Feb; 127(3):377-383. PubMed ID: 33762029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, double-blind, placebo-controlled trial to evaluate the hypoglycemic efficacy of the mcIRBP-19-containing
    Yang YS; Wu NY; Kornelius E; Huang CN; Yang NC
    Food Nutr Res; 2022; 66():. PubMed ID: 35140559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of the key metabolic pathways, glycolysis and lipogenesis, of oral cancer by bitter melon extract.
    Sur S; Nakanishi H; Flaveny C; Ippolito JE; McHowat J; Ford DA; Ray RB
    Cell Commun Signal; 2019 Oct; 17(1):131. PubMed ID: 31638999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lower hypoglycemic but higher antiatherogenic effects of bitter melon than glibenclamide in type 2 diabetic patients.
    Inayat U Rahman ; Khan RU; Khalil Ur Rahman ; Bashir M
    Nutr J; 2015 Jan; 14():13. PubMed ID: 25623883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative Pre-clinical Efficacy of Chinese and Indian Cultivars of Bitter Melon (
    Kandhari K; Paudel S; Raina K; Agarwal C; Kant R; Wempe MF; O'Bryant C; Agarwal R
    J Cancer Prev; 2021 Dec; 26(4):266-276. PubMed ID: 35047453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Momordica charantia on insulin resistance and visceral obesity in mice on high-fat diet.
    Shih CC; Lin CH; Lin WL
    Diabetes Res Clin Pract; 2008 Aug; 81(2):134-43. PubMed ID: 18550200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bitter melon (Momordica charantia) extract suppresses adrenocortical cancer cell proliferation through modulation of the apoptotic pathway, steroidogenesis, and insulin-like growth factor type 1 receptor/RAC-α serine/threonine-protein kinase signaling.
    Brennan VC; Wang CM; Yang WH
    J Med Food; 2012 Apr; 15(4):325-34. PubMed ID: 22191569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promise of bitter melon (Momordica charantia) bioactives in cancer prevention and therapy.
    Raina K; Kumar D; Agarwal R
    Semin Cancer Biol; 2016 Oct; 40-41():116-129. PubMed ID: 27452666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The metabolic effect of
    Laczkó-Zöld E; Csupor-Löffler B; Kolcsár EB; Ferenci T; Nan M; Tóth B; Csupor D
    Front Nutr; 2023; 10():1200801. PubMed ID: 38274207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracts of Momordica charantia suppress postprandial hyperglycemia in rats.
    Uebanso T; Arai H; Taketani Y; Fukaya M; Yamamoto H; Mizuno A; Uryu K; Hada T; Takeda E
    J Nutr Sci Vitaminol (Tokyo); 2007 Dec; 53(6):482-8. PubMed ID: 18202535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of Momordica charantia (bitter melon) supplementation in patients with primary knee osteoarthritis: A single-blinded, randomized controlled trial.
    Soo May L; Sanip Z; Ahmed Shokri A; Abdul Kadir A; Md Lazin MR
    Complement Ther Clin Pract; 2018 Aug; 32():181-186. PubMed ID: 30057048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bitter gourd reduces elevated fasting plasma glucose levels in an intervention study among prediabetics in Tanzania.
    Krawinkel MB; Ludwig C; Swai ME; Yang RY; Chun KP; Habicht SD
    J Ethnopharmacol; 2018 Apr; 216():1-7. PubMed ID: 29339109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoglycemic effect of bitter melon compared with metformin in newly diagnosed type 2 diabetes patients.
    Fuangchan A; Sonthisombat P; Seubnukarn T; Chanouan R; Chotchaisuwat P; Sirigulsatien V; Ingkaninan K; Plianbangchang P; Haines ST
    J Ethnopharmacol; 2011 Mar; 134(2):422-8. PubMed ID: 21211558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.